Document is current
Any future updates will be listed below
-
Authors
Cacciaglia, Raffaele https://orcid.org/0000-0002-9216-949X
Salvadó, Gemma https://orcid.org/0000-0002-5210-9230
Molinuevo, José Luis
Shekari, Mahnaz
Falcon, Carles
Operto, Gregory
Suárez-Calvet, Marc https://orcid.org/0000-0002-2993-569X
Milà-Alomà, Marta
Sala, Arianna https://orcid.org/0000-0001-8121-0891
Rodriguez-Vieitez, Elena https://orcid.org/0000-0002-6639-8141
Kollmorgen, Gwendlyn
Suridjan, Ivonne
Blennow, Kaj
Zetterberg, Henrik https://orcid.org/0000-0003-3930-4354
Gispert, Juan Domingo https://orcid.org/0000-0002-6155-0642
,
,
Arenaza-Urquijo, Eider
Beteta, Annabella
Brugulat-Serrat, Anna
Cañas, Alba
Cumplido, Irene
Deulofeu, Carme
Dominguez, Ruth
Emilio, Maria
Fauria, Karine
Fuentes, Sherezade
González-de-Echavarri, José María
Grau-Rivera, Oriol
Hernandez, Laura
Huesa, Gema
Huguet, Jordi
Knezevic, Iva
Marne, Paula
Minguillon, Carolina
Menchón, Tania
Pascual, Maria
Polo, Albina
Pradas, Sandra
Sánchez-Benavides, Gonzalo
Sala-Vila, Aleix
Soteras, Anna
Tenas, Laia
Vilanova, Marc
Vilor-Tejedor, Natalia
- License Information
-
More Information
Article History
Received: 5 July 2021
Revised: 20 December 2021
Accepted: 4 January 2022
First Online: 2 March 2022
Competing interests
: JLM has served/serves as a consultant or at advisory boards for the following for-profit companies, or has given lectures in symposia sponsored by the following for-profit companies: Roche Diagnostics, Genentech, Novartis, Lundbeck, Oryzon, Biogen, Lilly, Janssen, Green Valley, MSD, Eisai, Alector, BioCross, GE Healthcare, ProMIS Neurosciences, NovoNordisk, Zambón, Cytox and Nutricia. MSC has given lectures in symposia sponsored by ROCHE DIAGNOSTICS, S.L.U. GK is a full-time employee of Roche Diagnostics GmbH. IS is a full-time employee and shareholder of Roche Diagnostics International Lda. HZ has served at scientific advisory boards for Denali, Roche Diagnostics, Wave, Samumed, Siemens Healthineers, Pinteon Therapeutics and CogRx, has given lectures in symposia sponsored by Fujirebio, Alzecure and Biogen, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). The rest of the authors have no conflict of interest to declare.
